STOCK TITAN

Sila Realty Trust, Inc. 10-Q Filings

SILA NYSE

Every 10-Q that Sila Realty Trust, Inc. (SILA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow SILA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SILA filings page.

Rhea-AI Summary

Sila Realty Trust reported higher first-quarter 2026 results and agreed to be acquired in an all-cash deal. Net income attributable to common stockholders rose to $12.4 million from $7.9 million, with basic EPS increasing to $0.23 from $0.14, as total revenues grew to $52.7 million from $48.3 million.

Results benefited from property acquisitions, completed developments, and $2.5 million of gains on four asset sales, while interest expense climbed to $9.0 million and the company incurred $1.9 million of merger-related costs and $1.0 million of demolition costs. The portfolio comprised 137 healthcare properties, 98.7% leased.

On April 19, 2026, affiliates of Blue Owl Real Estate Capital agreed to acquire all outstanding shares for $30.38 per share in a transaction valued at about $2.4 billion, unanimously approved by the board and expected to close in the second or third quarter of 2026, subject to stockholder and customary approvals. At closing, Sila will go private and its shares will be delisted. The merger agreement includes a potential termination payment of approximately $55.7 million in specified circumstances, and the company may pay up to two regular quarterly dividends before closing, including a $0.40 per-share dividend authorized for June 4, 2026.

Rhea-AI Summary

Sila Realty Trust (SILA) reported Q3 2025 results with total revenues of $49.8 million, up from $46.1 million a year ago, driven by higher rental revenue. Quarterly net income attributable to common stockholders was $11.6 million, similar to last year. For the first nine months, revenues were $146.8 million and net income was $28.1 million.

The company acquired six healthcare properties for $148.9 million year to date, expanding its net-leased portfolio. Interest expense rose to $8.5 million in the quarter and $23.6 million year to date, reflecting higher borrowings. Year‑to‑date impairment charges totaled $6.8 million, including $3.5 million related to the Stoughton Healthcare Facility; a demolition plan also accelerated depreciation, reducing EPS by $0.02 for the quarter and year to date.

Sila entered a new $600 million revolving credit agreement and ended the quarter with $676.0 million outstanding across its unsecured credit facility. The Board authorized a quarterly dividend of $0.40 per share and established a $250 million ATM program with no issuances to date. As of September 30, 2025, 54,876,558 shares were outstanding.